Abbott has issued a recall for select HeartMate mobile power units used with its HeartMate3 and HeartMate III left-ventricular assist systems due to risk of sudden power loss that could lead to ...

Pharmacotherapy for advanced heart failure patients with a HeartMate 3 left ventricular assist device (LVAD) is being simplified following US Food and Drug Administration approval of a labeling change ...

Abbott has recalled the HeartMate Touch Communication System (version 1.0.32), which monitors patients with an implantable HeartMate 3 left ventricular assist device, because the pump may unexpectedly ...

Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it received final ...

Lifesaving therapy offers hope for patients with advanced heart failure, serving as a bridge to heart transplantation or long-term therapy. WASHINGTON, Nov. 17, 2025 /PRNewswire/ -- MedStar Washington ...

The FDA said Abbott (NYSE:ABT) has issued a corrective recall for its HeartMate Touch Communication System for use with its HeartMate 3 Left Ventricular Assist Device and HeartMate System Controller.

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

The long-term use of ventricular assist devices is becoming a problem for at least some of these devices, as demonstrated by the recall of the Heartmate II and Heartmate 3 devices by Abbott ...

(RTTNews) - Abbott's (ABT) new data show that an Aspirin-free medication regimen benefits people with its HeartMate 3 heart pump. According to Abbott, the new late-breaking data show advanced heart ...

Abbott Laboratories, Inc. ABT recently announced that the FDA has approved a change of label for its HeartMate 3 left ventricular assist device (LVAD or heart pump). The development, meant exclusively ...

INTEGRIS is a national leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts. The health care system was recently the first in the country to ...